Author

Georg H. Waetzig

MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
MICROBIOME MODIFICATION AND IMPROVEMENT OF SIGNS AND SYMPTOMS OF COVID-19: ILEOCOLONIC-RELEASE NICOTINAMIDE IN A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

Georg H. Waetzig  et al.

CHROMOCOLONOSCOPY WITH MICROENCAPSULATED PATENT BLUE V - AN EFFECTIVE OPTION FOR COLONIC MUCOSAL STAINING
CHROMOCOLONOSCOPY WITH MICROENCAPSULATED PATENT BLUE V - AN EFFECTIVE OPTION FOR COLONIC MUCOSAL STAINING

Georg H. Waetzig  et al.

Item 1 - 2 / 2
1